Abbott Laboratories Stock News

Deep brain stimulation is defined as a surgery that involves the implantation of an electrical device in the body. This device is responsible for sending electrical signals to the areas of brain, which are responsible for body movement. World Deep

ASEAN and North Asian Point of Care/Rapid Diagnostics Market analysis report is sure to help boost sales and improve return on investment (ROI). The research and analysis carried out in this ASEAN and North Asian Point of Care/Rapid Diagnostics Market

Global Electroceutical Devices Market was valued US$ 17.1 billion in 2018, and is projected to exhibit a CAGR of 6.8% over the forecast period (2018 - 2026). As an alternative to drug-based therapies, electroceuticals are medical devices that use electrical

Blood Testing Market The global blood testing market was valued at USD 54.1212 billion in 2018 and is projected to reach a value of USD 67.50 billion by 2026, registering a CAGR of 2.8% during the forecast period, 20192026. Blood testing is

City Holding Co. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT) by 3.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,653 shares of the healthcare product makers stock after selling 1,559 shares during the period. Abbott Laboratories []

Keeler Thomas Management LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT) by 2.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,529 shares of the healthcare product makers stock after selling 659 shares during the quarter. Keeler Thomas Management LLCs []

Lathrop Investment Management Corp lessened its stake in Abbott Laboratories (NYSE:ABT) by 2.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,175 shares of the healthcare product makers stock after selling 100 shares during the period. Lathrop Investment []

Analysts expect Abbott Laboratories (NYSE:ABT) to report $1.16 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Abbott Laboratories earnings, with the highest EPS estimate coming in at $1.20 and the lowest estimate coming in at $1.12. Abbott Laboratories posted earnings of $1.45 per share in []

First Citizens Financial Corp lowered its stake in Abbott Laboratories (NYSE:ABT) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,846 shares of the healthcare product makers stock after selling 100 shares during the quarter. First Citizens Financial Corps holdings in []

Overview Drugs affect individuals in various ways. For example, one drug may cause an increased heart rate, slightly faster breathing and an increase in blood pressure while another may cause drowsiness, lack of focus and memory loss. These differences in the

Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.

Home Medical Equipment Market research report covering the current trend and effect on the business of COVID-19. This intelligence report includes investigations based on Current scenarios, Historical records, and future predictions. The thorough research report contains all the vital information

The Hemostasis and Coagulation Analyzer Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of

Columbia Trust Co 01012016 lifted its holdings in shares of Abbott Laboratories (NYSE:ABT) by 9.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,730 shares of the healthcare product makers stock after acquiring an additional 516 shares during the quarter. Columbia Trust Co 01012016s []

Northwest Bancshares Inc. grew its holdings in Abbott Laboratories (NYSE:ABT) by 1.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,758 shares of the healthcare product maker’s stock after purchasing an additional 109 shares during the quarter. Northwest Bancshares Inc.’s holdings […]